MetLife Investment Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$658K Hold
27,547
﹤0.01% 1545
2025
Q1
$685K Sell
27,547
-336
-1% -$8.35K ﹤0.01% 1549
2024
Q4
$525K Buy
27,883
+1,471
+6% +$27.7K ﹤0.01% 1771
2024
Q3
$398K Hold
26,412
﹤0.01% 1904
2024
Q2
$756K Buy
26,412
+2,422
+10% +$69.3K ﹤0.01% 1504
2024
Q1
$701K Hold
23,990
﹤0.01% 1501
2023
Q4
$809K Hold
23,990
0.01% 1422
2023
Q3
$736K Hold
23,990
0.01% 1398
2023
Q2
$961K Buy
23,990
+319
+1% +$12.8K 0.01% 1289
2023
Q1
$966K Hold
23,671
0.01% 1235
2022
Q4
$914K Hold
23,671
0.01% 1265
2022
Q3
$1.26M Hold
23,671
0.01% 1080
2022
Q2
$1.38M Hold
23,671
0.01% 1055
2022
Q1
$1.81M Buy
23,671
+8,425
+55% +$643K 0.01% 1040
2021
Q4
$917K Hold
15,246
0.01% 1165
2021
Q3
$854K Sell
15,246
-1,510
-9% -$84.6K 0.01% 1207
2021
Q2
$1.02M Hold
16,756
0.01% 1151
2021
Q1
$1.17M Sell
16,756
-1,751
-9% -$123K 0.01% 1084
2020
Q4
$1.11M Hold
18,507
0.01% 1083
2020
Q3
$1.11M Hold
18,507
0.01% 976
2020
Q2
$971K Hold
18,507
0.01% 1051
2020
Q1
$621K Hold
18,507
0.01% 1103
2019
Q4
$838K Hold
18,507
0.01% 1183
2019
Q3
$705K Hold
18,507
0.01% 1238
2019
Q2
$805K Hold
18,507
0.01% 1218
2019
Q1
$704K Hold
18,507
0.01% 1245
2018
Q4
$796K Hold
18,507
0.01% 1117
2018
Q3
$910K Hold
18,507
0.01% 1176
2018
Q2
$593K Hold
18,507
0.01% 1306
2018
Q1
$576K Hold
18,507
0.01% 1290
2017
Q4
$845K Buy
+18,507
New +$845K 0.01% 1103